{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:29:09Z","timestamp":1792520949780,"version":"4.5.0"},"reference-count":187,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry &amp; Energy","doi-asserted-by":"publisher","award":["20012892"],"award-info":[{"award-number":["20012892"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jeonbuk National University","award":["20012892"],"award-info":[{"award-number":["20012892"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cannabidiol (CBD), a non-psychoactive phytocannabinoid abundant in Cannabis sativa, has gained considerable attention for its anti-inflammatory, antioxidant, analgesic, and neuroprotective properties. It exhibits the potential to prevent or slow the progression of various diseases, ranging from malignant tumors and viral infections to neurodegenerative disorders and ischemic diseases. Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, and viral hepatitis stand as prominent causes of morbidity and mortality in chronic liver diseases globally. The literature has substantiated CBD\u2019s potential therapeutic effects across diverse liver diseases in in vivo and in vitro models. However, the precise mechanism of action remains elusive, and an absence of evidence hinders its translation into clinical practice. This comprehensive review emphasizes the wealth of data linking CBD to liver diseases. Importantly, we delve into a detailed discussion of the receptors through which CBD might exert its effects, including cannabinoid receptors, CB1 and CB2, peroxisome proliferator-activated receptors (PPARs), G protein-coupled receptor 55 (GPR55), transient receptor potential channels (TRPs), and their intricate connections with liver diseases. In conclusion, we address new questions that warrant further investigation in this evolving field.<\/jats:p>","DOI":"10.3390\/ijms25042370","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T05:39:56Z","timestamp":1708321196000},"page":"2370","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The Role of Cannabidiol in Liver Disease: A Systemic Review"],"prefix":"10.3390","volume":"25","author":[{"given":"Si","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Jeonbuk National University Medical School, Jeonju 54896, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6746-6364","authenticated-orcid":false,"given":"Jeon-Kyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute of New Drug Development, School of Pharmacy, Jeonbuk National University, Jeonju 54896, Jeonbuk, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Castillo-Arellano, J., Canseco-Alba, A., Cutler, S.J., and Le\u00f3n, F. (2023). The Polypharmacological Effects of Cannabidiol. Molecules, 28.","DOI":"10.3390\/molecules28073271"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","article-title":"Cannabidiol: Pharmacology and therapeutic targets","volume":"238","author":"Britch","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wang, X., Zhang, H., Liu, Y., Xu, Y., Yang, B., Li, H., and Chen, L. (2023). An overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives. Bioorg. Chem., 140.","DOI":"10.1016\/j.bioorg.2023.106810"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/1319-3767.114505","article-title":"The role of endocannabinoids system in fatty liver disease and therapeutic potentials","volume":"19","author":"Alswat","year":"2013","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3889\/oamjms.2019.194","article-title":"AM-1241 CB2 Receptor Agonist Attenuates Inflammation, Apoptosis and Stimulate Progenitor Cells in Bile Duct Ligated Rats","volume":"7","author":"Mahmoud","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rao, M., Chen, D., Zhan, P., and Jiang, J. (2019). MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway. Biol. Direct., 14.","DOI":"10.1186\/s13062-019-0241-1"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12064","DOI":"10.1038\/s41598-017-10924-8","article-title":"Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41366-021-00967-3","article-title":"Combination of TRP channel dietary agonists induces energy expending and glucose utilizing phenotype in HFD-fed mice","volume":"46","author":"Kaur","year":"2022","journal-title":"Int. J. Obes."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3389\/fphar.2019.01198","article-title":"2-APB and CBD-Mediated Targeting of Charged Cytotoxic Compounds into Tumor Cells Suggests the Involvement of TRPV2 Channels","volume":"10","author":"Shilo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jhep.2015.01.001","article-title":"Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis","volume":"62","author":"Silvestri","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21224","DOI":"10.1002\/jcp.28728","article-title":"Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-\u03baB and NLRP3 inflammasome pathway","volume":"234","author":"Huang","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/can.2022.0014","article-title":"Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock?","volume":"8","author":"Marcellin","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ben-Cnaan, E., Permyakova, A., Azar, S., Hirsch, S., Baraghithy, S., Hinden, L., and Tam, J. (2022). The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105610"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2013.12.026","article-title":"Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy","volume":"68","author":"Yang","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"724747","DOI":"10.3389\/fphar.2021.724747","article-title":"CBD Alleviates Liver Injuries in Alcoholics with High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome-Pyroptosis Pathway","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mbaye, B., Borentain, P., Magdy Wasfy, R., Alou, M.T., Armstrong, N., Mottola, G., Meddeb, L., Ranque, S., G\u00e9rolami, R., and Million, M. (2022). Endogenous Ethanol and Triglyceride Production by Gut Pichia kudriavzevii, Candida albicans and Candida glabrata Yeasts in Non-Alcoholic Steatohepatitis. Cells, 11.","DOI":"10.3390\/cells11213390"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/s41467-023-39028-w","article-title":"Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae","volume":"14","author":"Gan","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s42238-022-00137-w","article-title":"THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet","volume":"4","author":"Gorelick","year":"2022","journal-title":"J. Cannabis Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/JOE-20-0018","article-title":"SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD","volume":"245","author":"Deng","year":"2020","journal-title":"J. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/can.2020.0013","article-title":"Cannabis Extracts Affected Metabolic Syndrome Parameters in Mice Fed High-Fat\/Cholesterol Diet","volume":"5","author":"Gorelick","year":"2020","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"981817","DOI":"10.3389\/fphar.2022.981817","article-title":"Cannabidiol markedly alleviates skin and liver fibrosis","volume":"13","author":"Prados","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"115374","DOI":"10.1016\/j.ecoenv.2023.115374","article-title":"Cannabidiol alleviates perfluorooctane sulfonate-induced macrophage extracellular trap mediate inflammation and fibrosis in mice liver","volume":"263","author":"Luo","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Patil, A.S., Mahajan, U.B., Agrawal, Y.O., Patil, K.R., Patil, C.R., Ojha, S., Sharma, C., and Goyal, S.N. (2020). Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review. Biomed. Pharmacother., 132.","DOI":"10.1016\/j.biopha.2020.110889"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14083","DOI":"10.1096\/fj.202000975R","article-title":"A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol","volume":"34","author":"Sunda","year":"2020","journal-title":"FASEB J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1038\/cddis.2011.52","article-title":"Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis","volume":"2","author":"Lim","year":"2011","journal-title":"Cell Death Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fphar.2019.00627","article-title":"Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain","volume":"10","author":"Naassila","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2009.04.021","article-title":"Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation","volume":"51","author":"Magen","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Sadowska, O., Baranowska-Kuczko, M., Gromotowicz-Pop\u0142awska, A., Biernacki, M., Kicman, A., Malinowska, B., Kasacka, I., Krzy\u017cewska, A., and Koz\u0142owska, H. (2020). Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197077"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Krzy\u017cewska, A., Baranowska-Kuczko, M., Kasacka, I., and Koz\u0142owska, H. (2023). Cannabidiol alleviates right ventricular fibrosis by inhibiting the transforming growth factor \u03b2 pathway in monocrotaline-induced pulmonary hypertension in rats. Biochim. Biophys. Acta Mol. Basis Dis., 1869.","DOI":"10.1016\/j.bbadis.2023.166753"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Mart\u00edn, A., Navarrete, C., Garrido-Rodr\u00edguez, M., Prados, M.E., Caprioglio, D., Appendino, G., and Mu\u00f1oz, E. (2021). EHP-101 alleviates angiotensin II-induced fibrosis and inflammation in mice. Biomed. Pharmacother., 142.","DOI":"10.1016\/j.biopha.2021.112007"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"115914","DOI":"10.1016\/j.envres.2023.115914","article-title":"The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma","volume":"228","author":"Ebrahimi","year":"2023","journal-title":"Environ. Res."},{"key":"ref_36","first-page":"e24576","article-title":"Lower Rates of Hepatocellular Carcinoma Observed Among Cannabis Users: A Population-Based Study","volume":"14","author":"ElTelbany","year":"2022","journal-title":"Cureus"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/bs.apha.2017.04.002","article-title":"Cannabinoids as Anticancer Drugs","volume":"80","author":"Ramer","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kis, B., Ifrim, F.C., Buda, V., Avram, S., Pavel, I.Z., Antal, D., Paunescu, V., Dehelean, C.A., Ardelean, F., and Diaconeasa, Z. (2019). Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235905"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tajik, T., Baghaei, K., Moghadam, V.E., Farrokhi, N., and Salami, S.A. (2022). Extracellular vesicles of cannabis with high CBD content induce anticancer signaling in human hepatocellular carcinoma. Biomed. Pharmacother., 152.","DOI":"10.1016\/j.biopha.2022.113209"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Viereckl, M.J., Krutsinger, K., Apawu, A., Gu, J., Cardona, B., Barratt, D., and Han, Y. (2022). Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways. Biomolecules, 12.","DOI":"10.3390\/biom12060854"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fphar.2018.00889","article-title":"Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer","volume":"9","author":"Kosgodage","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s42238-023-00190-z","article-title":"Cannabis sativa demonstrates anti-hepatocellular carcinoma potentials in animal model: In silico and in vivo studies of the involvement of Akt","volume":"5","author":"Akinloye","year":"2023","journal-title":"J. Cannabis Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Buchtova, T., Lukac, D., Skrott, Z., Chroma, K., Bartek, J., and Mistrik, M. (2023). Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032885"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Shangguan, F., Zhou, H., Ma, N., Wu, S., Huang, H., Jin, G., Wu, S., Hong, W., Zhuang, W., and Xia, H. (2021). A Novel Mechanism of Cannabidiol in Suppressing Hepatocellular Carcinoma by Inducing GSDME Dependent Pyroptosis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.697832"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Jeon, Y., Kim, T., Kwon, H., Kim, J.K., Park, Y.T., Ham, J., and Kim, Y.J. (2023). Cannabidiol Enhances Cabozantinib-Induced Apoptotic Cell Death via Phosphorylation of p53 Regulated by ER Stress in Hepatocellular Carcinoma. Cancers, 15.","DOI":"10.3390\/cancers15153987"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bph.13345","article-title":"GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis","volume":"173","author":"Kargl","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sea, Y.L., Gee, Y.J., Lal, S.K., and Choo, W.S. (2023). Cannabis as antivirals. J. Appl. Microbiol., 134.","DOI":"10.1093\/jambio\/lxac036"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"926696","DOI":"10.3389\/fimmu.2022.926696","article-title":"Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophages","volume":"13","author":"Tomer","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"eabi6110","DOI":"10.1126\/sciadv.abi6110","article-title":"Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses","volume":"8","author":"Nguyen","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"870787","DOI":"10.3389\/fimmu.2022.870787","article-title":"Cannabidiol and SARS-CoV-2 Infection","volume":"13","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1111\/bph.15157","article-title":"The potential of cannabidiol in the COVID-19 pandemic","volume":"177","author":"Esposito","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/1947601912466556","article-title":"Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium","volume":"3","author":"Maor","year":"2012","journal-title":"Genes. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0974-8490.199780","article-title":"Potential of Cannabidiol for the Treatment of Viral Hepatitis","volume":"9","author":"Lowe","year":"2017","journal-title":"Pharmacogn. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1586\/14737167.2015.1076337","article-title":"The cost-effectiveness of novel direct acting antiviral agent therapies for the treatment of chronic hepatitis C","volume":"15","author":"Bickerstaff","year":"2015","journal-title":"Expert. Rev. Pharmacoecon Outcomes Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jtemb.2013.07.001","article-title":"Protective effect of cannabidiol against cadmium hepatotoxicity in rats","volume":"27","author":"Fouad","year":"2013","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"523418","DOI":"10.1155\/2015\/523418","article-title":"Cannabidiol rescues acute hepatic toxicity and seizure induced by cocaine","volume":"2015","author":"Vilela","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"705402","DOI":"10.3389\/fphar.2021.705402","article-title":"Cannabis sativa L. (var. indica) Exhibits Hepatoprotective Effects by Modulating Hepatic Lipid Profile and Mitigating Gluconeogenesis and Cholinergic Dysfunction in Oxidative Hepatic Injury","volume":"12","author":"Erukainure","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10620-019-05756-7","article-title":"Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis","volume":"65","author":"Mathur","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Hegde, V.L., Nagarkatti, P.S., and Nagarkatti, M. (2011). Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018281"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejphar.2011.08.048","article-title":"Therapeutic potential of cannabidiol against ischemia\/reperfusion liver injury in rats","volume":"670","author":"Fouad","year":"2011","journal-title":"Eur, J. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.freeradbiomed.2011.02.021","article-title":"Cannabidiol protects against hepatic ischemia\/reperfusion injury by attenuating inflammatory signaling and response, oxidative\/nitrative stress, and cell death","volume":"50","author":"Mukhopadhyay","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"20230047","DOI":"10.1002\/EXP.20230047","article-title":"The pharmacology and therapeutic role of cannabidiol in diabetes","volume":"3","author":"Zhang","year":"2023","journal-title":"Exploration"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/08916930500356674","article-title":"Cannabidiol lowers incidence of diabetes in non-obese diabetic mice","volume":"39","author":"Weiss","year":"2006","journal-title":"Autoimmunity."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Berk, K., Konstantynowicz-Nowicka, K., Charytoniuk, T., Harasim-Symbor, E., and Chabowski, A. (2022). Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105382"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.26606","article-title":"Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides","volume":"59","author":"Cinar","year":"2014","journal-title":"Hepatology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dc16-0650","article-title":"Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study","volume":"39","author":"Jadoon","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1242\/dev.121731","article-title":"Cannabinoid receptor signaling regulates liver development and metabolism","volume":"143","author":"Liu","year":"2016","journal-title":"Development"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1476-511X-13-173","article-title":"Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model","volume":"13","author":"Shi","year":"2014","journal-title":"Lipids Health Dis."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"De Nunzio, V., Carrieri, L., Scavo, M.P., Lippolis, T., Cofano, M., Caponio, G.R., Tutino, V., Rizzi, F., Depalo, N., and Osella, A.R. (2023). Plasma-Derived Exosomes from NAFLD Patients Modulate the Cannabinoid Receptors\u2019 Expression in Cultured HepaRG Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021739"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.omtn.2020.04.010","article-title":"Cannabinoid Receptor 1\/miR-30b-5p Axis Governs Macrophage NLRP3 Expression and Inflammasome Activation in Liver Inflammatory Disease","volume":"20","author":"Yang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/acsptsci.0c00213","article-title":"Peripherally Selective CB1 Receptor Antagonist Improves Symptoms of Metabolic Syndrome in Mice","volume":"4","author":"Khan","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Dibba, P., Li, A., Cholankeril, G., Iqbal, U., Gadiparthi, C., Khan, M.A., Kim, D., and Ahmed, A. (2018). Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease. Medicines, 5.","DOI":"10.3390\/medicines5020047"},{"key":"ref_74","first-page":"169","article-title":"The Effect of CB1 Antagonism on Hepatic Oxidative\/Nitrosative Stress and Inflammation in Nonalcoholic Fatty Liver Disease","volume":"28","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.molmet.2017.08.011","article-title":"Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice","volume":"6","author":"Jourdan","year":"2017","journal-title":"Mol. Metab."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.30364","article-title":"Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure Through Sirtuin-1\/Mechanistic Target of Rapamycin Complex 2 and 5\u2032Adenosine Monophosphate-Activated Protein Kinase Signaling","volume":"69","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e60771","DOI":"10.7554\/eLife.60771","article-title":"CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance","volume":"9","author":"Drori","year":"2020","journal-title":"Elife"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1590\/1516-4446-2017-2231","article-title":"Gender differences of cannabis smoking on serum leptin levels: Population-based study","volume":"40","author":"Moreira","year":"2018","journal-title":"Braz. J. Psychiatry"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.110.168187","article-title":"A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys","volume":"335","author":"Wagner","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2011.11.001","article-title":"A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men","volume":"1431","author":"Riggs","year":"2012","journal-title":"Brain Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2337\/dc12-2303","article-title":"Metabolic effects of chronic cannabis smoking","volume":"36","author":"Muniyappa","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3389\/fimmu.2017.01214","article-title":"Cannabinoid Receptor 1 Participates in Liver Inflammation by Promoting M1 Macrophage Polarization via RhoA\/NF-\u03baB p65 and ERK1\/2 Pathways, Respectively, in Mouse Liver Fibrogenesis","volume":"8","author":"Tian","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e152242","DOI":"10.1172\/JCI152242","article-title":"Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD","volume":"131","author":"Wang","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2119\/molmed.2011.00149","article-title":"Cannabinoid receptor type I modulates alcohol-induced liver fibrosis","volume":"17","author":"Patsenker","year":"2011","journal-title":"Mol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","article-title":"Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver","volume":"7","author":"Jeong","year":"2008","journal-title":"Cell Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/acs.jmedchem.7b01820","article-title":"Blocking Alcoholic Steatosis in Mice with a Peripherally Restricted Purine Antagonist of the Type 1 Cannabinoid Receptor","volume":"61","author":"Amato","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2337\/db20-0078","article-title":"Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms","volume":"69","author":"Roger","year":"2020","journal-title":"Diabetes"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"van der Poorten, D., Shahidi, M., Tay, E., Sesha, J., Tran, K., McLeod, D., Milliken, J.S., Ho, V., Hebbard, L.W., and Douglas, M.W. (2010). Hepatitis C virus induces the cannabinoid receptor 1. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012841"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41419-020-03261-8","article-title":"Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-\u03baB signaling","volume":"11","author":"Kim","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_90","first-page":"954","article-title":"Analysis of Direct Effects of the CB1 Receptor Antagonist Rimonabant on Fatty Acid Oxidation and Glycogenolysis in Liver and Muscle Cells in vitro","volume":"84","author":"Wied","year":"2019","journal-title":"Biochemistry"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/hep.24524","article-title":"Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice","volume":"54","author":"Louvet","year":"2011","journal-title":"Hepatology"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Deveaux, V., Cadoudal, T., Ichigotani, Y., Teixeira-Clerc, F., Louvet, A., Manin, S., Nhieu, J.T., Belot, M.P., Zimmer, A., and Even, P. (2009). Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005844"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s00125-010-1894-6","article-title":"Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age","volume":"53","author":"Agudo","year":"2010","journal-title":"Diabetologia"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1478-3231.2010.02298.x","article-title":"Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes","volume":"30","author":"Spahr","year":"2010","journal-title":"Liver Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/mnfr.201600197","article-title":"\u03b2-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes","volume":"60","author":"Kamikubo","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bph.13722","article-title":"\u03b2-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice","volume":"175","author":"Varga","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"153960","DOI":"10.1016\/j.phymed.2022.153960","article-title":"Schisandrin B targets cannabinoid 2 receptor in Kupffer cell to ameliorate CCl4-induced liver fibrosis by suppressing NF-\u03baB and p38 MAPK pathway","volume":"98","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"28806","DOI":"10.1038\/srep28806","article-title":"The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway","volume":"6","author":"Lodder","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1478-3231.2011.02496.x","article-title":"Role of cannabinoid receptors in alcoholic hepatic injury: Steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts","volume":"31","author":"Trebicka","year":"2011","journal-title":"Liver Int."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"20587384211035251","DOI":"10.1177\/20587384211035251","article-title":"The protective effect of cannabinoid type II receptor agonist AM1241 on ConA-induced liver injury in mice via mitogen-activated protein kinase signalling pathway","volume":"35","author":"Wu","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cgh.2013.05.008","article-title":"Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C","volume":"12","author":"Coppola","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Sagnelli, C., Uberti-Foppa, C., Hasson, H., Bellini, G., Minichini, C., Salpietro, S., Messina, E., Barbanotti, D., Merli, M., and Punzo, F. (2017). Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV\/HCV coinfected patients. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181890"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/rheumatology\/ket447","article-title":"Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis","volume":"53","author":"Gui","year":"2014","journal-title":"Rheumatology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3945\/jn.110.135210","article-title":"PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver","volume":"141","author":"Abdelmegeed","year":"2011","journal-title":"J. Nutr."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"16154","DOI":"10.1074\/jbc.M400346200","article-title":"Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate","volume":"279","author":"Gervois","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2004.09.110","article-title":"PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats","volume":"324","author":"Toyama","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"42530","DOI":"10.18632\/oncotarget.6466","article-title":"Oleoylethanolamide, an endogenous PPAR-\u03b1 ligand, attenuates liver fibrosis targeting hepatic stellate cells","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Scandiffio, R., Bonzano, S., Cottone, E., Shrestha, S., Bossi, S., De Marchis, S., Maffei, M.E., and Bovolin, P. (2023). Beta-Caryophyllene Modifies Intracellular Lipid Composition in a Cell Model of Hepatic Steatosis by Acting through CB2 and PPAR Receptors. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076060"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"25448","DOI":"10.1074\/jbc.M301189200","article-title":"Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells","volume":"278","author":"Hoekstra","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.0511253103","article-title":"PPARdelta regulates glucose metabolism and insulin sensitivity","volume":"103","author":"Lee","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1074\/jbc.M110.138115","article-title":"Role of peroxisome proliferator-activated receptor {delta}\/{beta} in hepatic metabolic regulation","volume":"286","author":"Liu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1152\/physiolgenomics.00127.2009","article-title":"Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta\/delta in regulation of gene expression in mouse liver","volume":"41","author":"Sanderson","year":"2010","journal-title":"Physiol. Genom."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.biocel.2010.02.006","article-title":"Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro","volume":"42","author":"Yu","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3892\/mmr.2021.12463","article-title":"PPAR\u03b3 attenuates hepatic inflammation and oxidative stress of non-alcoholic steatohepatitis via modulating the miR-21-5p\/SFRP5 pathway","volume":"24","author":"Zhang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-2952(01)00817-6","article-title":"Toxicological consequences of altered peroxisome proliferator-activated receptor gamma (PPARgamma) expression in the liver: Insights from models of obesity and type 2 diabetes","volume":"63","author":"Boelsterli","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1011927113563","article-title":"Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob\/ob mouse model of non-insulin dependent diabetes mellitus","volume":"224","author":"Rahimian","year":"2001","journal-title":"Mol. Cell Biochem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/jc.2010-2129","article-title":"Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: An additional reinforcing lipogenic mechanism to SREBP-1c induction","volume":"96","author":"Pettinelli","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"101087","DOI":"10.1016\/j.molmet.2020.101087","article-title":"Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53\/miRNA-22\/SIRT1\/PPAR\u03b1 dependent","volume":"42","author":"Azar","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"154771","DOI":"10.1016\/j.phymed.2023.154771","article-title":"Cannabidiol goes nuclear: The role of PPAR\u03b3","volume":"114","author":"Khosropoor","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Esposito, G., Scuderi, C., Valenza, M., Togna, G.I., Latina, V., De Filippis, D., Cipriano, M., Carrat\u00f9, M.R., Iuvone, T., and Steardo, L. (2011). Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028668"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Atalay, S., Jarocka-Karpowicz, I., and Skrzydlewska, E. (2019). Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants, 9.","DOI":"10.3390\/antiox9010021"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.drudis.2013.12.005","article-title":"A potential role for GPR55 in the regulation of energy homeostasis","volume":"19","author":"Simcocks","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"170251","DOI":"10.1016\/j.peptides.2019.170251","article-title":"CRISPR\/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function","volume":"125","author":"McCloskey","year":"2020","journal-title":"Peptides"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ijo.2015.209","article-title":"Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity","volume":"40","author":"Meadows","year":"2016","journal-title":"Int. J. Obes."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1096\/fj.201800171R","article-title":"GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues","volume":"33","author":"Lipina","year":"2019","journal-title":"FASEB J."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.biopha.2018.12.126","article-title":"Novel protective effect of O-1602 and abnormal cannabidiol, GPR55 agonists, on ER stress-induced apoptosis in pancreatic \u03b2-cells","volume":"111","author":"Vong","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hep.31290","article-title":"The L-\u03b1-Lysophosphatidylinositol\/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis","volume":"73","author":"Fondevila","year":"2021","journal-title":"Hepatology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/db11-0649","article-title":"The L-\u03b1-lysophosphatidylinositol\/GPR55 system and its potential role in human obesity","volume":"61","author":"Whyte","year":"2012","journal-title":"Diabetes"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1463-1326.2011.01515.x","article-title":"The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats","volume":"14","author":"Pulido","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"44234","DOI":"10.1074\/jbc.M112.364109","article-title":"The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55","volume":"287","author":"Kargl","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/cr.2011.60","article-title":"GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils","volume":"21","author":"Balenga","year":"2011","journal-title":"Cell Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphar.2015.00069","article-title":"The therapeutic potential of orphan GPCRs, GPR35 and GPR55","volume":"6","author":"Shore","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e9811","DOI":"10.7717\/peerj.9811","article-title":"High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or \u0394(9)-tetrahydrocannabivarin on weight gain","volume":"8","author":"Wargent","year":"2020","journal-title":"PeerJ"},{"key":"ref_139","first-page":"771","article-title":"Advances in the Physiology of GPR55 in the Central Nervous System","volume":"15","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"McCloskey, A.G., Miskelly, M.G., Lafferty, R.A., Flatt, P.R., and McKillop, A.M. (2023). Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice. Biochem. Pharmacol., 208.","DOI":"10.1016\/j.bcp.2022.115398"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-024-1088-4_1","article-title":"TRP Channel Classification","volume":"976","author":"Li","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-981-10-7757-9_6","article-title":"Transient Receptor Potential (TRP) Channels","volume":"87","author":"Samanta","year":"2018","journal-title":"Subcell. Biochem."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"7362875","DOI":"10.1155\/2019\/7362875","article-title":"Mechanism for Regulation of Melanoma Cell Death via Activation of Thermo-TRPV4 and TRPV2","volume":"2019","author":"Zheng","year":"2019","journal-title":"J. Oncol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10549-020-05673-8","article-title":"TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K\/AKT pathway","volume":"182","author":"Zhang","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/978-94-007-0265-3_35","article-title":"Expression and function of TRP channels in liver cells","volume":"704","author":"Rychkov","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2022.12.031","article-title":"Capsaicin receptor TRPV1 maintains quiescence of hepatic stellate cells in the liver via recruitment of SARM1","volume":"78","author":"Tao","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3100943","DOI":"10.1155\/2022\/3100943","article-title":"Transient Receptor Potential Vanilloid-1 (TRPV1) Alleviates Hepatic Fibrosis via TGF-\u03b2 Signaling","volume":"2022","author":"Qian","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Xie, C., Liu, G., Li, M., Fang, Y., Qian, K., Tang, Y., Wu, X., Lei, X., Li, X., and Liu, Q. (2019). Targeting TRPV1 on cellular plasticity regulated by Ovol 2 and Zeb 1 in hepatocellular carcinoma. Biomed. Pharmacother., 118.","DOI":"10.1016\/j.biopha.2019.109270"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1620\/tjem.256.131","article-title":"TRPV1 Protect against Hyperglycemia and Hyperlipidemia Induced Liver Injury via OPA1 in Diabetes","volume":"256","author":"Wang","year":"2022","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00424-012-1078-y","article-title":"TRPV1 activation prevents nonalcoholic fatty liver through UCP2 upregulation in mice","volume":"463","author":"Li","year":"2012","journal-title":"Pflugers Arch."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Lacerda, J.T., Gomes, P.R.L., Zanetti, G., Mezzalira, N., Lima, O.G., de Assis, L.V.M., Guler, A., Castrucci, A.M., and Moraes, M.N. (2022). Lack of TRPV1 Channel Modulates Mouse Gene Expression and Liver Proteome with Glucose Metabolism Changes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137014"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/1873-3468.14105","article-title":"Mice lacking endogenous TRPV1 express reduced levels of thermogenic proteins and are susceptible to diet-induced obesity and metabolic dysfunction","volume":"595","author":"Baskaran","year":"2021","journal-title":"FEBS Lett."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.apsb.2022.09.005","article-title":"Expression and functions of transient receptor potential channels in liver diseases","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm. Sin. B."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"113042","DOI":"10.1016\/j.ejmech.2020.113042","article-title":"Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity","volume":"213","author":"Mallet","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","article-title":"Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation","volume":"143","author":"Costa","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.biopha.2018.06.029","article-title":"Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer","volume":"105","author":"Hu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1021\/acs.jnatprod.0c00668","article-title":"Cannabitwinol, a Dimeric Phytocannabinoid from Hemp, Cannabis sativa L., Is a Selective Thermo-TRP Modulator","volume":"83","author":"Chianese","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_158","unstructured":"Clinicaltrials.gov (2020, January 01). Study to Assess the Effect of Cannabidiol on Liver Fat Levels in Subjects with Fatty Liver Disease, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT01284634."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MEG.0000000000001263","article-title":"Marijuana is not associated with progression of hepatic fibrosis in liver disease: A systematic review and meta-analysis","volume":"31","author":"Farooqui","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"106267","DOI":"10.1016\/j.phrs.2022.106267","article-title":"Biological effects of cannabidiol on human cancer cells: Systematic review of the literature","volume":"181","author":"Valenti","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.21873\/anticanres.12924","article-title":"Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol","volume":"38","author":"Kenyon","year":"2018","journal-title":"Anticancer. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"716","DOI":"10.7150\/jca.28246","article-title":"New Prospect for Cancer Cachexia: Medical Cannabinoid","volume":"10","author":"Wang","year":"2019","journal-title":"J. Cancer"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J. Pain. Symptom Manag."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s13063-020-04541-6","article-title":"Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"21","author":"Hardy","year":"2020","journal-title":"Trials"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11010-016-2702-5","article-title":"Cannabidiol promotes browning in 3T3-L1 adipocytes","volume":"416","author":"Parray","year":"2016","journal-title":"Mol. Cell Biochem."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Bielawiec, P., Harasim-Symbor, E., Sztolsztener, K., Konstantynowicz-Nowicka, K., and Chabowski, A. (2021). Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6\/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity. Nutrients, 13.","DOI":"10.3390\/nu13051603"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40263-020-00741-5","article-title":"Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications","volume":"34","author":"Perucca","year":"2020","journal-title":"CNS Drugs"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Abbotts, K.S.S., Ewell, T.R., Butterklee, H.M., Bomar, M.C., Akagi, N., Dooley, G.P., and Bell, C. (2022). Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function. Nutrients, 14.","DOI":"10.3390\/nu14102152"},{"key":"ref_171","first-page":"1","article-title":"Mechanisms of Action and Pharmacokinetics of Cannabis","volume":"25","author":"Chayasirisobhon","year":"2020","journal-title":"Perm. J."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12325-022-02345-5","article-title":"Examining the Systemic Bioavailability of Cannabidiol and Tetrahydrocannabinol from a Novel Transdermal Delivery System in Healthy Adults: A Single-Arm, Open-Label, Exploratory Study","volume":"40","author":"Varadi","year":"2023","journal-title":"Adv. Ther."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/bms.1200130206","article-title":"Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration","volume":"13","author":"Ohlsson","year":"1986","journal-title":"Biomed. Environ. Mass. Spectrom."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jat\/bkab059","article-title":"Urinary Pharmacokinetic Profile of Cannabidiol (CBD), \u03949-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration","volume":"46","author":"Sholler","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Johnson, D.A., Funnell, M.P., Heaney, L.M., Cable, T.G., Wheeler, P.C., Bailey, S.J., Clifford, T., and James, L.J. (Cannabis Cannabinoid Res., 2023). Cannabidiol Oil Ingested as Sublingual Drops or Within Gelatin Capsules Shows Similar Pharmacokinetic Profiles in Healthy Males, Cannabis Cannabinoid Res., ahead of print.","DOI":"10.1089\/can.2023.0117"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"MacNair, L., Kulpa, J., Hill, M.L., Eglit, G.M.L., Mosesova, I., Bonn-Miller, M.O., and Peters, E.N. (Cannabis Cannabinoid Res., 2023). Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy Adults, Cannabis Cannabinoid Res., ahead of print.","DOI":"10.1089\/can.2022.0345"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/01.ftd.0000177223.19294.5c","article-title":"Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract","volume":"27","author":"Nadulski","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects","volume":"32","author":"Taylor","year":"2019","journal-title":"CNS Drugs"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Martinez Naya, N., Kelly, J., Corna, G., Golino, M., Polizio, A.H., Abbate, A., Toldo, S., and Mezzaroma, E. (2024). An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects. Molecules, 29.","DOI":"10.3390\/molecules29020473"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/17512433.2022.2148655","article-title":"Cannabinoids and drug metabolizing enzymes: Potential for drug-drug interactions and implications for drug safety and efficacy","volume":"15","author":"Bardhi","year":"2022","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"108586","DOI":"10.1016\/j.neuropharm.2021.108586","article-title":"Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics","volume":"191","author":"Schlag","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref_183","unstructured":"Greenwich Biosciences (2018). Epidiolex [Package Insert], Greenwich Biosciences."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and Side Effects of Cannabidiol, a Cannabis Sativa Constituent. Curr","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Drug Saf."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/can.2021.0114","article-title":"Observed Impact of Long-Term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults","volume":"8","author":"Kaufmann","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1089\/can.2022.0191","article-title":"Re: \u201cObserved Impact of Long-Term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults\u201d and a Recent Announcement of a New Cannabidiol Safety Study","volume":"7","author":"Caputi","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse Effects of Cannabidiol:A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"45","author":"Chesney","year":"2020","journal-title":"Neuropsychopharmacology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/4\/2370\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:01:14Z","timestamp":1760104874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/4\/2370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,17]]},"references-count":187,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["ijms25042370"],"URL":"https:\/\/doi.org\/10.3390\/ijms25042370","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,17]]}}}